These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30559973)

  • 1. Monitoring cognitive change in multiple sclerosis using a computerized cognitive battery.
    De Meijer L; Merlo D; Skibina O; Grobbee EJ; Gale J; Haartsen J; Maruff P; Darby D; Butzkueven H; Van der Walt A
    Mult Scler J Exp Transl Clin; 2018; 4(4):2055217318815513. PubMed ID: 30559973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive performance in relapsing remitting multiple sclerosis: a longitudinal study in daily practice using a brief computerized cognitive battery.
    Edgar C; Jongen PJ; Sanders E; Sindic C; Goffette S; Dupuis M; Jacquerye P; Guillaume D; Reznik R; Wesnes K
    BMC Neurol; 2011 Jun; 11():68. PubMed ID: 21649910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
    López-Góngora M; Querol L; Escartín A
    BMC Neurol; 2015 Mar; 15():40. PubMed ID: 25886168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new look at cognitive functioning in pediatric MS.
    Krupp LB; Waubant E; Waltz M; Casper TC; Belman A; Wheeler Y; Ness J; Graves J; Gorman M; Benson L; Mar S; Goyal M; Schreiner T; Weinstock-Guttman B; Rodriguez M; Tillema JM; Lotze T; Aaen G; Rensel M; Rose J; Chitinis T; George A; Charvet LE;
    Mult Scler; 2023 Jan; 29(1):140-149. PubMed ID: 36189711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalamic-hippocampal-prefrontal disruption in relapsing-remitting multiple sclerosis.
    Kern KC; Gold SM; Lee B; Montag M; Horsfall J; O'Connor MF; Sicotte NL
    Neuroimage Clin; 2015; 8():440-7. PubMed ID: 26106524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis.
    Portaccio E; Goretti B; Zipoli V; Siracusa G; Sorbi S; Amato MP
    Clin Neuropsychol; 2009 Feb; 23(2):268-75. PubMed ID: 18609336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosis.
    Yam C; Merlo D; Stankovich J; Darby D; Gresle M; Kalincik T; Kilpatrick TJ; Lechner-Scott J; Taylor B; Barnett M; Butzkueven H; van der Walt A
    Mult Scler Relat Disord; 2020 Aug; 43():102212. PubMed ID: 32474286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the validity of a computer-generated cognitive screening instrument for patients with multiple sclerosis.
    Lapshin H; Lanctôt KL; O'Connor P; Feinstein A
    Mult Scler; 2013 Dec; 19(14):1905-12. PubMed ID: 23652217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR lesion load and cognitive function in patients with relapsing-remitting multiple sclerosis.
    Fulton JC; Grossman RI; Udupa J; Mannon LJ; Grossman M; Wei L; Polansky M; Kolson DL
    AJNR Am J Neuroradiol; 1999; 20(10):1951-5. PubMed ID: 10588124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients.
    Niccolai C; Portaccio E; Goretti B; Hakiki B; Giannini M; Pastò L; Righini I; Falautano M; Minacapelli E; Martinelli V; Incerti C; Nocentini U; Fenu G; Cocco E; Marrosu MG; Garofalo E; Ambra FI; Maddestra M; Consalvo M; Viterbo RG; Trojano M; Losignore NA; Zimatore GB; Pietrolongo E; Lugaresi A; Pippolo L; Roscio M; Ghezzi A; Castellano D; Stecchi S; Amato MP
    BMC Neurol; 2015 Oct; 15():204. PubMed ID: 26472052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting cognitive dysfunction in a busy multiple sclerosis clinical setting: a computer generated approach.
    Lapshin H; Audet B; Feinstein A
    Eur J Neurol; 2014 Feb; 21(2):281-6. PubMed ID: 24200243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
    Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS).
    O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C
    Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olfactory function and cognition in relapsing-remitting and secondary-progressive multiple sclerosis.
    Carotenuto A; Costabile T; Moccia M; Falco F; Scala MR; Russo CV; Saccà F; De Rosa A; Lanzillo R; Brescia Morra V
    Mult Scler Relat Disord; 2019 Jan; 27():1-6. PubMed ID: 30273697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple Sclerosis.
    Merlo D; Stankovich J; Bai C; Kalincik T; Zhu C; Gresle M; Lechner-Scott J; Kilpatrick T; Barnett M; Taylor B; Darby D; Butzkueven H; Van der Walt A
    Neurology; 2021 Nov; 97(20):e2020-e2031. PubMed ID: 34556562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS.
    Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F
    Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early imaging predictors of long-term outcomes in relapse-onset multiple sclerosis.
    Brownlee WJ; Altmann DR; Prados F; Miszkiel KA; Eshaghi A; Gandini Wheeler-Kingshott CAM; Barkhof F; Ciccarelli O
    Brain; 2019 Aug; 142(8):2276-2287. PubMed ID: 31342055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of Diffusion Modeling of Cogstate Brief Battery Test Performance in Detecting Mild Cognitive Impairment.
    Mulhauser K; Giordani B; Kavcic V; May LDN; Bhaumik A; Shair S; Votruba K
    Assessment; 2023 Apr; 30(3):847-855. PubMed ID: 35016575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in pediatric-onset multiple sclerosis is detected by the Brief International Cognitive Assessment for Multiple Sclerosis and computerized cognitive testing.
    Charvet LE; Shaw M; Frontario A; Langdon D; Krupp LB
    Mult Scler; 2018 Apr; 24(4):512-519. PubMed ID: 28322606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.